CDKs remain attractive targets for anti-proliferative cancer chemotherapy. they play a central role in cell division and growth.  Amongst the cell cycle CDKs, CDK2 has attracted the most attention and its exploitation as a drug target based on structure-based drug design. In this article, we will introduce a potent...